Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

Resource and Technical AdvanceIn-Press PreviewCell biologyPulmonology Open Access | 10.1172/jci.insight.199660

Pulmonary fibroblast subsets demonstrate differentially enriched signaling pathways during fibrosis resolution and repair

Daniel G. Foster,1 Nomin Javkhlan,2 Bart P. Black,2 Brian E. Vestal,3 David W.H. Riches,2 and Elizabeth F. Redente4

1Department of Pharmaceutical Sciences, University of Colorado School of Pharmacy, Aurora, United States of America

2Department of Pediatrics, National Jewish Health, Denver, United States of America

3Center for Genes, Environment and Health, National Jewish Health, Denver, United States of America

4Department of Pharmaceutical Sciences, National Jewish Health, Denver, United States of America

Find articles by Foster, D. in: PubMed | Google Scholar |

1Department of Pharmaceutical Sciences, University of Colorado School of Pharmacy, Aurora, United States of America

2Department of Pediatrics, National Jewish Health, Denver, United States of America

3Center for Genes, Environment and Health, National Jewish Health, Denver, United States of America

4Department of Pharmaceutical Sciences, National Jewish Health, Denver, United States of America

Find articles by Javkhlan, N. in: PubMed | Google Scholar

1Department of Pharmaceutical Sciences, University of Colorado School of Pharmacy, Aurora, United States of America

2Department of Pediatrics, National Jewish Health, Denver, United States of America

3Center for Genes, Environment and Health, National Jewish Health, Denver, United States of America

4Department of Pharmaceutical Sciences, National Jewish Health, Denver, United States of America

Find articles by Black, B. in: PubMed | Google Scholar

1Department of Pharmaceutical Sciences, University of Colorado School of Pharmacy, Aurora, United States of America

2Department of Pediatrics, National Jewish Health, Denver, United States of America

3Center for Genes, Environment and Health, National Jewish Health, Denver, United States of America

4Department of Pharmaceutical Sciences, National Jewish Health, Denver, United States of America

Find articles by Vestal, B. in: PubMed | Google Scholar

1Department of Pharmaceutical Sciences, University of Colorado School of Pharmacy, Aurora, United States of America

2Department of Pediatrics, National Jewish Health, Denver, United States of America

3Center for Genes, Environment and Health, National Jewish Health, Denver, United States of America

4Department of Pharmaceutical Sciences, National Jewish Health, Denver, United States of America

Find articles by Riches, D. in: PubMed | Google Scholar |

1Department of Pharmaceutical Sciences, University of Colorado School of Pharmacy, Aurora, United States of America

2Department of Pediatrics, National Jewish Health, Denver, United States of America

3Center for Genes, Environment and Health, National Jewish Health, Denver, United States of America

4Department of Pharmaceutical Sciences, National Jewish Health, Denver, United States of America

Find articles by Redente, E. in: PubMed | Google Scholar |

Published May 5, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.199660.
Copyright © 2026, Foster et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published May 5, 2026 - Version history
View PDF
Abstract

The lungs have a remarkable capacity to undergo homoeostatic repair and regeneration after injury, which often occurs in patients with acute respiratory distress syndrome (ARDS) and in the single-dose bleomycin mouse model. Fibroblasts are critical mediators of fibrotic disease and RNA sequencing has identified significant heterogeneity within pulmonary fibroblast populations. However, the contribution of distinct fibroblast subsets to the repair process has been understudied compared to their role in fibrosis initiation and progression. Therefore, we sought to define the transcriptional landscape of three phenotypically-defined fibroblast subsets that occupy discrete spatial locations in naïve lungs. Using TdTomato-lineage tracing approaches, we identified and interrogated collagen1a1+ (Col1a1) fibroblasts, perilipin 2+ (Plin2) alveolar fibroblasts, and a-smooth muscle actin+ (Acta2) myofibroblasts during fibrosis development and resolution after single-dose bleomycin. Quantification of fibroblast numbers showed that all three subsets expand during fibrosis and contract towards naïve levels with resolution. Principal component and gene-set enrichment analyses indicated that each subset undergoes major transcriptomic shifts during fibrosis development, converging on a similar pro-fibrotic transcriptional profile. However, during resolution, Plin2+ and Acta2+ fibroblasts revert towards a pre-fibrotic transcriptional state, whereas Col1a1+ fibroblasts acquire a distinct program that suggests suggesting an active role in mediating the repair processes.

Graphical Abstract
graphical abstract
Supplemental material

View

Version history
  • Version 1 (May 5, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts